Tehniat Faraz Ahmed
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Tehniat Faraz Ahmed has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
- Affan Ahmed
3rd Year MBBS Student, Dow Medical College, Dow University of Health Sciences, Karachi, Pakistan
6 shared publications Fauzia Imtiaz
4 shared publicationsAffan Ahmed
Dow University of Health Sciences, Karachi, Sindh, Pakistan
2 shared publicationsUzma Zaman
2 shared publicationsAbdul Hannan
Department of Hematology/Oncology, Simmons Cancer Institute at Southern Illinois University School of Medicine, Springfield, IL, USA
1 shared publication- Adeel Masood
Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas
1 shared publication
Latest Publications
- Open Access
- 23 December 2025
- Published by Wiley in Alzheimer's & Dementia
- Vol. 21 (S1) , e101481
In Silico Identification of MicroRNAs Targeting Shared Pathways in Insulin Resistance and Alzheimer's Disease
Background: The unclear pathophysiology of Alzheimer's disease complicates treatment development. Risk factors like diabetes, metabolic syndrome, and APOE4 allele are closely linked to insulin resistance (IR), but mechanisms connecting these conditions are unclear. Epigenetic regulation through microRNAs has been implicated in the regulation of both IR and AD, yet no studies have identified microRNAs simultaneously targeting both pathways. This study aims to bioinformatically identify such microRNAs and analyze functional annotation of their target genes to uncover shared regulatory mechanisms linking IR and AD. Method: Using five prediction tools and two databases of experimentally validated microRNA‐gene interactions we identified microRNAs targeting twenty key IR genes in humans (Table‐1). We assigned a predicted score (P1) to each interaction, adding a point (E1) for experimental validation to calculate a cumulative score (C1) and its average (T1). We further analyzed microRNAs with T1 scores above 1.0 for interactions with AD pathway genes using KEGG analysis and constructed protein‐protein interaction network with STRING to identify hub proteins. We re‐evaluated the microRNAs for targeting these genes, calculating cumulative (C2) and total scores (T2). We performed functional annotation of target genes for microRNAs with the highest T2 scores using DAVID. Retrieving Gene Ontology terms for biological processes and molecular functions, we identified common terms to highlight shared regulatory mechanisms linking IR and AD. Result: AKT3 had the most microRNA targets among insulin sensitivity regulators, and miR‐15a‐5p scored the highest among the selected microRNAs with high T1‐scores. Altogether, these microRNAs targeted 299 AD‐related genes, with miR‐16‐5p targeting the most. The top 10 hub genes in the AD protein‐protein interaction network are shown in Figure 1. Rescoring based on AD targets revealed miR‐7‐5p, let‐7a‐5p, let‐7b‐5p, miR‐15b‐5p, miR‐16‐5p, miR‐17‐5p, and miR‐424‐5p as the highest‐ranking microRNAs based on total scores (T2). Target genes of these microRNAs were found enriched in negative regulation of transcription by RNA polymerase II, chromatin remodeling, and G1/S transition of the mitotic cell cycle (Table‐2). Molecular functions enriched included protein binding and protein serine/threonine kinase activity. Conclusion: We recommend studying the identified microRNAs as a pathogenic link between AD and IR and as early biomarkers of AD in IR patients.
- 23 December 2025
- Published by Wiley in Alzheimer's & Dementia
- Vol. 21 (S1) , e101481
Open AccessIn Silico Identification of MicroRNAs Targeting Shared Pathways in Insulin Resistance and Alzheimer's Disease
Background: The unclear pathophysiology of Alzheimer's disease complicates treatment development. Risk factors like diabetes, metabolic syndrome, and APOE4 allele are closely linked to insulin resistance (IR), but mechanisms connecting these conditions are unclear. Epigenetic regulation through microRNAs has been implicated in the regulation of both IR and AD, yet no studies have identified microRNAs simultaneously targeting both pathways. This study aims to bioinformatically identify such microRNAs and analyze functional annotation of their target genes to uncover shared regulatory mechanisms linking IR and AD. Method: Using five prediction tools and two databases of experimentally validated microRNA‐gene interactions we identified microRNAs targeting twenty key IR genes in humans (Table‐1). We assigned a predicted score (P1) to each interaction, adding a point (E1) for experimental validation to calculate a cumulative score (C1) and its average (T1). We further analyzed microRNAs with T1 scores above 1.0 for interactions with AD pathway genes using KEGG analysis and constructed protein‐protein interaction network with STRING to identify hub proteins. We re‐evaluated the microRNAs for targeting these genes, calculating cumulative (C2) and total scores (T2). We performed functional annotation of target genes for microRNAs with the highest T2 scores using DAVID. Retrieving Gene Ontology terms for biological processes and molecular functions, we identified common terms to highlight shared regulatory mechanisms linking IR and AD. Result: AKT3 had the most microRNA targets among insulin sensitivity regulators, and miR‐15a‐5p scored the highest among the selected microRNAs with high T1‐scores. Altogether, these microRNAs targeted 299 AD‐related genes, with miR‐16‐5p targeting the most. The top 10 hub genes in the AD protein‐protein interaction network are shown in Figure 1. Rescoring based on AD targets revealed miR‐7‐5p, let‐7a‐5p, let‐7b‐5p, miR‐15b‐5p, miR‐16‐5p, miR‐17‐5p, and miR‐424‐5p as the highest‐ranking microRNAs based on total scores (T2). Target genes of these microRNAs were found enriched in negative regulation of transcription by RNA polymerase II, chromatin remodeling, and G1/S transition of the mitotic cell cycle (Table‐2). Molecular functions enriched included protein binding and protein serine/threonine kinase activity. Conclusion: We recommend studying the identified microRNAs as a pathogenic link between AD and IR and as early biomarkers of AD in IR patients.
- Open Access
- 28 June 2024
- Published by Pakistan Medical Association in Journal of the Pakistan Medical Association
- Vol. 74 (7) , 1397-1401
Assessing knowledge of dental house officers regarding dosage calculation and complications of local anaesthesia, in three tertiary care dental hospitals of DUHS, Karachi
Objective: To assess the knowledge and awareness of dental house officers regarding calculation of local anaesthesia dosage, and to evaluate differences in practices at various tertiary care facilities. Method: The cross-sectional study was conducted at three dental hospitals affiliated with Dow University of Health Sciences, Karachi from July to December 2022, and comprised house officers of either gender currently enrolled at the participating centres. Data was collected using a self-administered questionnaire to assess knowledge and awareness of local anaesthesia dosage calculation, administration methods, and common complications. Data was analysed using SPSS 26. Results: Of the 200 subjects approached, 136(68%) responded, and 89(65.4%) of them were females. Knowledge regarding the meaning of 2% lidocaine solution was low 45(33%), and 68(50%) subjects were knowledgeable about the maximum dosage of lidocaine with epinephrine. In terms of practice, lidocaine was the most commonly administered local anaesthetic 115(85%), followed by bupivacaine 15(11%). The majority of subjects administered local anaesthesia with vasoconstrictor 127(94%), but only 36(27%) performed aspiration during administration. Syncope 71(52%) was the most commonly reported complication, followed by lip/cheek/tongue biting by 35(26%). Conclusion: House officers’ knowledge level of local anaesthesia administration indicated the need for adequate training. Key Words: Local anaesthetics, Knowledge, Lignocaine, Drug dosage calculation.
- 28 June 2024
- Published by Pakistan Medical Association in Journal of the Pakistan Medical Association
- Vol. 74 (7) , 1397-1401
Open AccessAssessing knowledge of dental house officers regarding dosage calculation and complications of local anaesthesia, in three tertiary care dental hospitals of DUHS, Karachi
Objective: To assess the knowledge and awareness of dental house officers regarding calculation of local anaesthesia dosage, and to evaluate differences in practices at various tertiary care facilities. Method: The cross-sectional study was conducted at three dental hospitals affiliated with Dow University of Health Sciences, Karachi from July to December 2022, and comprised house officers of either gender currently enrolled at the participating centres. Data was collected using a self-administered questionnaire to assess knowledge and awareness of local anaesthesia dosage calculation, administration methods, and common complications. Data was analysed using SPSS 26. Results: Of the 200 subjects approached, 136(68%) responded, and 89(65.4%) of them were females. Knowledge regarding the meaning of 2% lidocaine solution was low 45(33%), and 68(50%) subjects were knowledgeable about the maximum dosage of lidocaine with epinephrine. In terms of practice, lidocaine was the most commonly administered local anaesthetic 115(85%), followed by bupivacaine 15(11%). The majority of subjects administered local anaesthesia with vasoconstrictor 127(94%), but only 36(27%) performed aspiration during administration. Syncope 71(52%) was the most commonly reported complication, followed by lip/cheek/tongue biting by 35(26%). Conclusion: House officers’ knowledge level of local anaesthesia administration indicated the need for adequate training. Key Words: Local anaesthetics, Knowledge, Lignocaine, Drug dosage calculation.
- Open Access
- 5 November 2023
- Published by Elsevier in IBRO Neuroscience Reports
- Vol. 15, S352
COMPARISON OF POTENTIAL PLASMA BIOMARKERS IN ALZHEIMER’S DISEASE AND OTHER NEURODEGENERATIVE DEMENTIAS IN PAKISTANI POPULATION
- 5 November 2023
- Published by Elsevier in IBRO Neuroscience Reports
- Vol. 15, S352
Open AccessCOMPARISON OF POTENTIAL PLASMA BIOMARKERS IN ALZHEIMER’S DISEASE AND OTHER NEURODEGENERATIVE DEMENTIAS IN PAKISTANI POPULATION
- Open Access
- 30 October 2023
- Published by Pakistan Medical Association in Journal of the Pakistan Medical Association
- Vol. 73 (11) , 2298
The road to crisis: State of Pakistan’s Research Output in Dementia
Dear Madam, With an estimated 6.5 million people living with dementia in the South Asian region, these areas are at the forefront of tackling the growing epidemic. However, there is a scarcity of population-based studies particularly in lower-middle-income countries, which hampers accurate estimation of the economic burden posed by dementia (1). Pakistan, with the world’s third largest growing population is a model of these countries. Although the Global Action Plan for Public Health Response to Dementia highlights seven action areas, the Global Dementia Observatory (GDO) report has Pakistan underperforming in almost all areas. In comparison, her neighbors, India, China and Iran are significantly better. With no health information systems for dementia, and no support or care for people with dementia, Pakistan has failed to consider dementia as a public health priority (1). Reports show that Pakistan is drafting a national policy for dementia, yet no surveys on national prevalence and cost have been conducted (2). Apart from an ageing population, low literacy levels and high prevalence of heart diseases and diabetes, make the population highly susceptible to developing AD in the coming future. Furthermore, a challenge especially to LMICs is the stigma associated with dementia and the lack of awareness, not just in the general population, but also in the healthcare providers. Alzheimer’s Disease International reports that almost 2 in 3 healthcare practitioners worldwide consider dementia as part of normal ageing (3). Only if these beliefs are reformed can the disease be tackled efficiently. For a nation with no infrastructure to support patients with AD and where MRI is unaffordable to the majority and scarcely available PET scans are not used for the diagnosis of AD, the population would rely on the establishment of fluid biomarkers not only for diagnosing AD, but for its identification at a stage where it is possible to reduce the years lost to dependence. Unfortunately, our search on PubMed and Google Scholar revealed only one AD biomarker study conducted by the current authors on our population (4). Recently a constructive step was taken by lay and professional experts where a SWOT analysis was done of dementia research capacity in Pakistan. ---Continue
- 30 October 2023
- Published by Pakistan Medical Association in Journal of the Pakistan Medical Association
- Vol. 73 (11) , 2298
Open AccessThe road to crisis: State of Pakistan’s Research Output in Dementia
Dear Madam, With an estimated 6.5 million people living with dementia in the South Asian region, these areas are at the forefront of tackling the growing epidemic. However, there is a scarcity of population-based studies particularly in lower-middle-income countries, which hampers accurate estimation of the economic burden posed by dementia (1). Pakistan, with the world’s third largest growing population is a model of these countries. Although the Global Action Plan for Public Health Response to Dementia highlights seven action areas, the Global Dementia Observatory (GDO) report has Pakistan underperforming in almost all areas. In comparison, her neighbors, India, China and Iran are significantly better. With no health information systems for dementia, and no support or care for people with dementia, Pakistan has failed to consider dementia as a public health priority (1). Reports show that Pakistan is drafting a national policy for dementia, yet no surveys on national prevalence and cost have been conducted (2). Apart from an ageing population, low literacy levels and high prevalence of heart diseases and diabetes, make the population highly susceptible to developing AD in the coming future. Furthermore, a challenge especially to LMICs is the stigma associated with dementia and the lack of awareness, not just in the general population, but also in the healthcare providers. Alzheimer’s Disease International reports that almost 2 in 3 healthcare practitioners worldwide consider dementia as part of normal ageing (3). Only if these beliefs are reformed can the disease be tackled efficiently. For a nation with no infrastructure to support patients with AD and where MRI is unaffordable to the majority and scarcely available PET scans are not used for the diagnosis of AD, the population would rely on the establishment of fluid biomarkers not only for diagnosing AD, but for its identification at a stage where it is possible to reduce the years lost to dependence. Unfortunately, our search on PubMed and Google Scholar revealed only one AD biomarker study conducted by the current authors on our population (4). Recently a constructive step was taken by lay and professional experts where a SWOT analysis was done of dementia research capacity in Pakistan. ---Continue
- Open Access
- 13 September 2023
- Published by Pakistan Medical Association in Journal of the Pakistan Medical Association
- Vol. 73 (10) , 2062-2064
Comparison of potential plasma biomarkers in Alzheimer’s disease and neurodegenerative dementias in Pakistani population
This study aimed to compare the mean plasma levels of Amyloid B42, Phosphorylated Tau and Neurofilament Light chain in patients diagnosed with Alzheimer’s Clinical Syndrome (ACS), and other neurodegenerative dementias to find affordable and less-invasive means of diagnosing Alzheimer’s disease (AD) early in its course. Blood samples of 36 subjects presenting with cognitive decline to the neurology OPDs of Dow and Civil hospitals, Karachi, were centrifuged, and plasma was stored at 80C. Before analysis, it was thawed at 4C and protein levels were measured through ELISA. Two-thirds of the patients were females but age distribution across both the groups was not significantly different (p 0.21). No difference was observed in the mean plasma concentrations of AB42, P-Tau, and NFL between the two groups (p-values 0.78 and 0.27 and 0.09 respectively). ---Continue
- 13 September 2023
- Published by Pakistan Medical Association in Journal of the Pakistan Medical Association
- Vol. 73 (10) , 2062-2064
Open AccessComparison of potential plasma biomarkers in Alzheimer’s disease and neurodegenerative dementias in Pakistani population
This study aimed to compare the mean plasma levels of Amyloid B42, Phosphorylated Tau and Neurofilament Light chain in patients diagnosed with Alzheimer’s Clinical Syndrome (ACS), and other neurodegenerative dementias to find affordable and less-invasive means of diagnosing Alzheimer’s disease (AD) early in its course. Blood samples of 36 subjects presenting with cognitive decline to the neurology OPDs of Dow and Civil hospitals, Karachi, were centrifuged, and plasma was stored at 80C. Before analysis, it was thawed at 4C and protein levels were measured through ELISA. Two-thirds of the patients were females but age distribution across both the groups was not significantly different (p 0.21). No difference was observed in the mean plasma concentrations of AB42, P-Tau, and NFL between the two groups (p-values 0.78 and 0.27 and 0.09 respectively). ---Continue
- Open Access
- 15 July 2023
- Published by Pakistan Medical Association in Journal of the Pakistan Medical Association
- Vol. 73 (8) , 1640-1646
Confronting challenges: an inductive thematic analysis of barriers and solutions to undergraduate medical research in Pakistan
Objectives: To qualitatively analyse the barriers in pursuing undergraduate research, and to propose solutions for the problems identified. Method: The qualitative study was conducted from May to October 2021 after approval from the institutional ethics review board of the Dow University of Health Sciences, Karachi, and comprised undergraduate students of either gender at various public and private medical universities across Pakistan having some level of research experience and good communication skills. Data triangulation was employed to collect qualitative data through open-ended survey, face-to-face interviews and focus group discussions. Using the information of one method to inform the rest, linked trajectories were established that allowed validation of information at each level. Data was coded manually by two researchers independently. Data was subjected to inductive thematic analysis. Results: Of the 33 subjects, 17(51.5%) were males, 17(51.5%) were from private medical colleges, 18(54.5%) were from Karachi, and 11(33.3%) were in the final year of medical school. Overall, 13(39.4%) students completed the open-ended survey, 6(18.2%) completed face-to-face interviews, and 14(42.4%) participated in focus group discussions. Thematic anlsysis showed that students were interested in research to improve their career prospects, but not all were passionate about it. Students were not satisfied with the quality of research being conducted Pakistan in the country. Dearth of motivated faculty, unavailability of well-maintained and digitalised data registries, ineffective research methodology teaching and lack of access to medical journals and research software were the major barriers in undergraduate research. Time constraint was a projecting problem which challenged the students. Frequent research workshops and conferences, strong networking, reorienting curriculum to provide early exposure to research and student-led initiatives were suggested to improve undergraduate research in Pakistan. Conclusion: Students’ lack of initiative coupled with administrative and faculty-related issues pose a serious threat to the future of evidence-based medicine. Proposed solutions offer a ray of hope to the future of undergraduate research in Pakistan. Key Words: Undergraduate medical education, Qualitative research, Focus groups, Interview, Pakistan.
- 15 July 2023
- Published by Pakistan Medical Association in Journal of the Pakistan Medical Association
- Vol. 73 (8) , 1640-1646
Open AccessConfronting challenges: an inductive thematic analysis of barriers and solutions to undergraduate medical research in Pakistan
Objectives: To qualitatively analyse the barriers in pursuing undergraduate research, and to propose solutions for the problems identified. Method: The qualitative study was conducted from May to October 2021 after approval from the institutional ethics review board of the Dow University of Health Sciences, Karachi, and comprised undergraduate students of either gender at various public and private medical universities across Pakistan having some level of research experience and good communication skills. Data triangulation was employed to collect qualitative data through open-ended survey, face-to-face interviews and focus group discussions. Using the information of one method to inform the rest, linked trajectories were established that allowed validation of information at each level. Data was coded manually by two researchers independently. Data was subjected to inductive thematic analysis. Results: Of the 33 subjects, 17(51.5%) were males, 17(51.5%) were from private medical colleges, 18(54.5%) were from Karachi, and 11(33.3%) were in the final year of medical school. Overall, 13(39.4%) students completed the open-ended survey, 6(18.2%) completed face-to-face interviews, and 14(42.4%) participated in focus group discussions. Thematic anlsysis showed that students were interested in research to improve their career prospects, but not all were passionate about it. Students were not satisfied with the quality of research being conducted Pakistan in the country. Dearth of motivated faculty, unavailability of well-maintained and digitalised data registries, ineffective research methodology teaching and lack of access to medical journals and research software were the major barriers in undergraduate research. Time constraint was a projecting problem which challenged the students. Frequent research workshops and conferences, strong networking, reorienting curriculum to provide early exposure to research and student-led initiatives were suggested to improve undergraduate research in Pakistan. Conclusion: Students’ lack of initiative coupled with administrative and faculty-related issues pose a serious threat to the future of evidence-based medicine. Proposed solutions offer a ray of hope to the future of undergraduate research in Pakistan. Key Words: Undergraduate medical education, Qualitative research, Focus groups, Interview, Pakistan.
- Open Access
- 1 July 2023
- Published by Springer Nature in Saudi Pharmaceutical Journal
- Vol. 31 (7) , 1202-1209
Plasma levels of phosphorylated tau and neurofilament light chain as potential biomarkers for Alzheimer’s disease: A biochemical analysis in Pakistani population
The National Institute on Aging-Alzheimer's Association's research framework in 2018 proposed a molecular construct for the diagnosis of Alzheimer’s disease (AD). Nonetheless, the clinical exclusionary strategy is still the mainstay of AD diagnosis in Pakistan. We looked at the plasma levels of amyloid beta-42 (Aβ-42), phosphorylated tau (P-tau), and neurofilament light (NFL) in patients with Alzheimer's clinical syndrome (ACS) and healthy controls (HC) from the Pakistani population to keep pace with the global efforts towards establishing accessible and affordable biochemical diagnostic markers for AD in Pakistan.
- 1 July 2023
- Published by Springer Nature in Saudi Pharmaceutical Journal
- Vol. 31 (7) , 1202-1209
Open AccessPlasma levels of phosphorylated tau and neurofilament light chain as potential biomarkers for Alzheimer’s disease: A biochemical analysis in Pakistani population
The National Institute on Aging-Alzheimer's Association's research framework in 2018 proposed a molecular construct for the diagnosis of Alzheimer’s disease (AD). Nonetheless, the clinical exclusionary strategy is still the mainstay of AD diagnosis in Pakistan. We looked at the plasma levels of amyloid beta-42 (Aβ-42), phosphorylated tau (P-tau), and neurofilament light (NFL) in patients with Alzheimer's clinical syndrome (ACS) and healthy controls (HC) from the Pakistani population to keep pace with the global efforts towards establishing accessible and affordable biochemical diagnostic markers for AD in Pakistan.
- 15 September 2021
- Published by Taylor & Francis in Expert Review of Hematology
- Vol. 14 (12) , 1071-1083
Advances in viral oncolytics for treatment of multiple myeloma – a focused review
Introduction: Oncolytic viruses are genetically engineered viruses that target myeloma-affected cells by detecting specific cell surface receptors (CD46, CD138), causing cell death by activating the signaling pathway to induce apoptosis or by immune-mediated cellular destruction. Although MM is a highly treatable but incurable disease, therapeutic advances with oncolytic viruses are an innovative treatment approach. Areas covered: This article summarizes oncolytic virotherapy advancements such as the therapeutic use of viruses by targeting cell surface proteins of myeloma cells as well as the carriers to deliver viruses to the target tissues safely. The major classes of viruses that have been studied for this include measles, myxoma, adenovirus, reovirus, vaccinia, vesicular-stomatitis virus, coxsackie, and others. The measles virus acts as oncolytic viral therapy by binding to the CD46 receptors on the myeloma cells to utilize its surface H protein. These H-protein and CD46 interactions lead to cellular syncytia formation resulting in cellular apoptosis. Vesicular-stomatitis virus acts by downregulation of anti-apoptotic factors (Mcl-2, BCL-2). Based upon the published literature searches till December 2020, we have summarized the data supporting the advances in viral oncolytic for the treatment of MM. Expert opinion: Oncolytic virotherapy is an experimental approach in multiple myeloma (MM); many issues need to be addressed for safe viral delivery to the target tissue.
- 15 September 2021
- Published by Taylor & Francis in Expert Review of Hematology
- Vol. 14 (12) , 1071-1083
Advances in viral oncolytics for treatment of multiple myeloma – a focused review
Introduction: Oncolytic viruses are genetically engineered viruses that target myeloma-affected cells by detecting specific cell surface receptors (CD46, CD138), causing cell death by activating the signaling pathway to induce apoptosis or by immune-mediated cellular destruction. Although MM is a highly treatable but incurable disease, therapeutic advances with oncolytic viruses are an innovative treatment approach. Areas covered: This article summarizes oncolytic virotherapy advancements such as the therapeutic use of viruses by targeting cell surface proteins of myeloma cells as well as the carriers to deliver viruses to the target tissues safely. The major classes of viruses that have been studied for this include measles, myxoma, adenovirus, reovirus, vaccinia, vesicular-stomatitis virus, coxsackie, and others. The measles virus acts as oncolytic viral therapy by binding to the CD46 receptors on the myeloma cells to utilize its surface H protein. These H-protein and CD46 interactions lead to cellular syncytia formation resulting in cellular apoptosis. Vesicular-stomatitis virus acts by downregulation of anti-apoptotic factors (Mcl-2, BCL-2). Based upon the published literature searches till December 2020, we have summarized the data supporting the advances in viral oncolytic for the treatment of MM. Expert opinion: Oncolytic virotherapy is an experimental approach in multiple myeloma (MM); many issues need to be addressed for safe viral delivery to the target tissue.
- 17 August 2021
- Published by Taylor & Francis in Expert Review of Vaccines
- Vol. 20 (9) , 1185-1193
Understanding COVID-19 vaccine acceptance in Pakistan: an echo of previous immunizations or prospect of change?
As countries ramp up their COVID-19 vaccination programs, attitudes of the population remain a determining player in the success of these plans. This study analyses the factors associated with inte...
- 17 August 2021
- Published by Taylor & Francis in Expert Review of Vaccines
- Vol. 20 (9) , 1185-1193
Understanding COVID-19 vaccine acceptance in Pakistan: an echo of previous immunizations or prospect of change?
As countries ramp up their COVID-19 vaccination programs, attitudes of the population remain a determining player in the success of these plans. This study analyses the factors associated with inte...
- Open Access
- 1 July 2021
- Published by Taylor & Francis in Journal of Blood Medicine
- Vol. ume 12, 529-550
Profile and Management of Toxicity of Selinexor and Belantamab Mafodotin for the Treatment of Triple Class Refractory Multiple Myeloma
Treatment options are limited for multiple myeloma patients who have developed four/five drug-refractory disease. Selinexor (Sel) and belantamab mafodotin (belamaf) were recently approved by the US FDA for treatment of RRMM. The toxicity profile of these drugs is a concern since these agents are used in patients who have already undergone multiple lines of treatment. In this review, we discuss the toxicity profile and strategies for the management of toxicities of Sel and belamaf for the treatment of RRMM. We conducted a comprehensive literature search on PubMed, Embase, Cochrane, and Clinicaltrials.gov using the terms “selinexor”, “belantamab”, “belamaf”, and “multiple myeloma” without applying any limitations based on the date of the study, language, or country of origin. The most common hematological toxicity associated with these two drugs is thrombocytopenia. Cytopenias, constitutional symptoms, gastrointestinal effects, and hyponatremia are the major toxicities of Sel. Keratopathy and anemia are the major toxicities of belamaf. Treatment modifications and dose interruption are usually needed when side effects are more than grade II. As these are newer drugs with limited data, continuous surveillance and monitoring are warranted during the treatment course with early mitigation strategies.
- 1 July 2021
- Published by Taylor & Francis in Journal of Blood Medicine
- Vol. ume 12, 529-550
Open AccessProfile and Management of Toxicity of Selinexor and Belantamab Mafodotin for the Treatment of Triple Class Refractory Multiple Myeloma
Treatment options are limited for multiple myeloma patients who have developed four/five drug-refractory disease. Selinexor (Sel) and belantamab mafodotin (belamaf) were recently approved by the US FDA for treatment of RRMM. The toxicity profile of these drugs is a concern since these agents are used in patients who have already undergone multiple lines of treatment. In this review, we discuss the toxicity profile and strategies for the management of toxicities of Sel and belamaf for the treatment of RRMM. We conducted a comprehensive literature search on PubMed, Embase, Cochrane, and Clinicaltrials.gov using the terms “selinexor”, “belantamab”, “belamaf”, and “multiple myeloma” without applying any limitations based on the date of the study, language, or country of origin. The most common hematological toxicity associated with these two drugs is thrombocytopenia. Cytopenias, constitutional symptoms, gastrointestinal effects, and hyponatremia are the major toxicities of Sel. Keratopathy and anemia are the major toxicities of belamaf. Treatment modifications and dose interruption are usually needed when side effects are more than grade II. As these are newer drugs with limited data, continuous surveillance and monitoring are warranted during the treatment course with early mitigation strategies.